MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

15 May 2023 Evaluate
The sales for the March 2023 quarter moved down to Rs. 729.42 millions as compared to Rs. 782.13 millions during the year-ago period.Profit saw a slight increase of 8.54%to Rs. 85.29  millions from Rs. 78.58 millions.Operating profit for the quarter ended March 2023 rose to 133.21 millions as compared to 122.72 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 729.42 782.13 -6.74 2750.52 3186.67 -13.69 2750.52 3186.67 -13.69
Other Income 26.86 22.79 17.86 76.12 126.40 -39.78 76.12 126.40 -39.78
PBIDT 133.21 122.72 8.55 356.96 782.09 -54.36 356.96 782.09 -54.36
Interest 3.22 3.74 -13.90 11.97 15.62 -23.37 11.97 15.62 -23.37
PBDT 129.99 118.98 9.25 344.99 766.47 -54.99 344.99 766.47 -54.99
Depreciation 19.17 18.80 1.97 78.99 76.73 2.95 78.99 76.73 2.95
PBT 110.82 100.18 10.62 266.00 689.74 -61.43 266.00 689.74 -61.43
TAX 25.53 21.60 18.19 64.81 167.28 -61.26 64.81 167.28 -61.26
Deferred Tax -3.97 -8.90 -55.39 -7.29 -4.22 72.75 -7.29 -4.22 72.75
PAT 85.29 78.58 8.54 201.19 522.46 -61.49 201.19 522.46 -61.49
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 18.26 15.69 16.39 12.98 24.54 -47.12 12.98 24.54 -47.12
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..